The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. BioAdaptives's quick ratio for the quarter that ended in Sep. 2024 was 0.02.
BioAdaptives has a quick ratio of 0.02. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for BioAdaptives's Quick Ratio or its related term are showing as below:
BDPT'
s Quick Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.99
Current: 0.02
During the past 9 years, BioAdaptives's highest Quick Ratio was 0.99. The lowest was 0.01. And the median was 0.04.
BDPT's Quick Ratio is ranked worse than 99.63% of 1908
companies
in the Consumer Packaged Goods industry
Industry Median: 1.09
vs BDPT: 0.02
BioAdaptives Quick Ratio Historical Data
The historical data trend for BioAdaptives's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioAdaptives's Quick Ratio
For the Packaged Foods subindustry, BioAdaptives's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives's Quick Ratio Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Quick Ratio distribution charts can be found below:
* The bar in red indicates where BioAdaptives's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
BioAdaptives's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioAdaptives (OTCPK:BDPT) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
BioAdaptives Quick Ratio Related Terms
Thank you for viewing the detailed overview of BioAdaptives's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDPT has been successfully added to your 